|
Volumn 23, Issue 8-9, 2004, Pages 1445-1450
|
Regulation of equilibrative nucleoside uptake by protein kinase inhibitors
|
Author keywords
CTP; Kinase inhibitors; Leukemia cells; Nucleoside transport
|
Indexed keywords
1 (4,5 DIHYDROXY 3 HYDROXYMETHYL 2 CYCLOPENTEN 1 YL)CYTOSINE;
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE;
2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE;
4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE;
4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE;
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE;
ADENOSINE TRIPHOSPHATE;
ARCYRIARUBIN;
CYTIDINE DERIVATIVE;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
GUANOSINE TRIPHOSPHATE;
IMATINIB;
INDIRUBIN;
LEFLUNOMIDE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
NUCLEOSIDE;
NUCLEOSIDE ANALOG;
OLOMOUCINE;
PROTEIN KINASE C INHIBITOR;
PROTEIN KINASE INHIBITOR;
RAPAMYCIN;
RO 316045;
ROSCOVITINE;
STAUROSPORINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
URIDINE DERIVATIVE;
URIDINE TRIPHOSPHATE;
CELL DIFFERENTIATION;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG DESIGN;
DRUG TARGETING;
HUMAN;
HUMAN CELL;
INHIBITION KINETICS;
LEUKEMIA CELL;
PROTEIN TRANSPORT;
REGULATORY MECHANISM;
TRANSPORT KINETICS;
ANIMALS;
BIOLOGICAL TRANSPORT;
CYTIDINE;
ENZYME INHIBITORS;
EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS;
EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1;
EQUILIBRATIVE-NUCLEOSIDE TRANSPORTER 2;
HUMANS;
K562 CELLS;
MODELS, BIOLOGICAL;
NEOPLASMS;
NUCLEOSIDES;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PROTEIN KINASE C;
PROTEIN KINASE INHIBITORS;
RATS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
ARA;
|
EID: 10344252311
PISSN: 15257770
EISSN: None
Source Type: Journal
DOI: 10.1081/NCN-200027667 Document Type: Conference Paper |
Times cited : (9)
|
References (18)
|